PATIENTS WITH NEUROLOGICAL DISEASES: RATIONALE FOR PHARMACOECONOMIC EVALUATION OF COST OPTIMIZATION FOR MANAGEMENT WITH NEURON-SPECIFIC PROTEINS ASSESSMENT AS MARKERS OF INCREASED BLOOD-BRAIN-BARRIER PERMEABILITY

D. V. Blinov

FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
Farmakoèkonomika

eng | рус

User

ISSN 2070-4909 (Print)
ISSN 2070-4933 (Online)

FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology

Advanced search

Archives

Download this PDF file

Fullscreen

For citations:

Blinov D.V. PATIENTS WITH NEUROLOGICAL DISEASES: RATIONALE FOR PHARMACOECONOMIC EVALUATION OF COST OPTIMIZATION FOR MANAGEMENT WITH NEURON-SPECIFIC PROTEINS ASSESSMENT AS MARKERS OF INCREASED BLOOD-BRAIN-BARRIER PERMEABILITY. FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2014;7(1):40-45. (In Russ.)

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

ISSN 2070-4909 (Print)
ISSN 2070-4933 (Online)

Username
Password
	Remember me

User

FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology

For citations:

Cookies policy